- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.2: 4 residues within 4Å:- Chain A: N.122, T.124, V.127, E.169
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.4: 9 residues within 4Å:- Chain A: T.108, N.234, T.236
- Chain B: R.455, K.456, S.457, N.458, L.459, K.460
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.5: 3 residues within 4Å:- Chain A: N.278, E.279, N.280
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.7: 5 residues within 4Å:- Chain A: N.715, F.716, T.717, L.920, Q.924
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Q.924
NAG-NAG-MAN.8: 4 residues within 4Å:- Chain A: N.799, S.801, Q.802, F.815
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.815
NAG-NAG-MAN.10: 4 residues within 4Å:- Chain A: N.1096, T.1098, H.1099, F.1101
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.11: 1 residues within 4Å:- Chain A: N.1132
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.13: 4 residues within 4Å:- Chain B: N.122, T.124, N.125, V.127
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.15: 8 residues within 4Å:- Chain B: T.108, N.234, T.236
- Chain C: R.455, K.456, S.457, N.458, L.459
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.16: 2 residues within 4Å:- Chain B: E.279, N.280
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.18: 3 residues within 4Å:- Chain B: N.715, L.920, Q.924
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Q.924
NAG-NAG-MAN.19: 3 residues within 4Å:- Chain B: N.799, S.801, Q.802
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.21: 3 residues within 4Å:- Chain B: N.1096, H.1099, F.1101
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.22: 1 residues within 4Å:- Chain B: N.1132
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.24: 4 residues within 4Å:- Chain C: N.122, T.124, N.125, V.127
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.26: 8 residues within 4Å:- Chain A: R.455, K.456, S.457, N.458, L.459
- Chain C: T.108, N.234, T.236
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.27: 3 residues within 4Å:- Chain C: N.278, E.279, N.280
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.29: 5 residues within 4Å:- Chain C: N.715, T.717, L.920, Q.924, Q.1069
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.920, C:Q.924
NAG-NAG-MAN.30: 3 residues within 4Å:- Chain C: N.799, S.801, Q.802
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.32: 3 residues within 4Å:- Chain C: N.1096, H.1099, F.1101
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.33: 1 residues within 4Å:- Chain C: N.1132
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.9: 4 residues within 4Å:- Chain A: S.702, A.704, E.1070, N.1072
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:A.704
NAG-NAG-FUC.20: 4 residues within 4Å:- Chain B: S.702, A.704, E.1070, N.1072
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:A.704
NAG-NAG-FUC.31: 4 residues within 4Å:- Chain C: S.702, A.704, E.1070, N.1072
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:A.704
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.34: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: K.147, N.149, M.153
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: N.329, Q.578, T.579
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain A: F.336, G.337, F.340, N.341
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.601
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: Y.653, N.655
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: N.707, G.1129
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain A: N.1156
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: K.147, N.148, N.149
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.329
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain B: F.336, G.337, F.340, N.341
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.601
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: Y.653, N.655
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain B: N.707, G.1129
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain B: N.1156
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain C: K.147, N.148, N.149, M.153
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.329, P.577
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain C: F.336, G.337, F.340, N.341
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.601
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain C: Y.653, N.655
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: N.707, G.1129
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1156
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
- Release Date
- 2023-08-09
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xing, X. et al., Structures of SARS-CoV-2 spike protein alert noteworthy sites for the potential approaching variants. Virol Sin (2022)
- Release Date
- 2023-08-09
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C